Post by SHL Medical

In lyophilized drug delivery, it is not enough for the system to work. The device, reconstitution approach, and assembly strategy must also be seamlessly aligned to support a realistic path to commercialization. At PFS and IDD West Coast, SHL Medical's Dr. Nina Fetz will be speaking about these early development considerations in lyophilized drug delivery, and what they can mean for pharma teams as they move beyond technical feasibility through a real-world case study. The session will also feature Reunite, our dual-chamber cartridge autoinjector for lyophilized drug delivery. Built with our proprietary Needle Isolation Technology (NIT), it simplifies a complex vial-based injection process into just three steps. Join us in San Diego to continue the conversation.